Low levels of 25-hydroxy vitamin D (25(OH)D) are associated with cardiovascular diseases. Herein, we tested the hypothesis that vitamin D deficiency could be a causal factor in atherosclerotic vascular changes and vascular calcification. Aortic root sections of vitamin D receptor knockout (VDR−/−) mice that were stained for vascular calcification and immunostained for osteoblastic differentiation factors showed more calcified areas and a higher expression of the osteogenic key factors Msx2, Bmp2, and Runx2 than the wild-type mice (P<0.01). Data from LDL receptor knockout (LDLR−/−) mice that were fed western diet with either low (50 IU/kg), recommended (1,000 IU/kg), or high (10,000 IU/kg) amounts of vitamin D3 over 16 weeks revealed increasing plasma concentrations of 25(OH)D (P<0.001) with increasing intake of vitamin D, whereas levels of calcium and phosphorus in plasma and femur were not influenced by the dietary treatment. Mice treated with the low vitamin D diet had more calcified lesions and a higher expression of Msx2, Bmp2, and Runx2 in aortic roots than mice fed recommended or high amounts of vitamin D (P<0.001). Taken together, these findings indicate vitamin D deficiency as a risk factor for aortic valve and aortic vessel calcification and a stimulator of osteogenic key factor expression in these vascular areas.
Citation: Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F, Stangl GI (2012) Vitamin D Receptor Deficiency and Low Vitamin D Diet Stimulate Aortic Calcification and Osteogenic Key Factor Expression in Mice. PLoS ONE 7(4): e35316. https://doi.org/10.1371/journal.pone.0035316
Editor: Olivier Kocher, Harvard Medical School, United States of America
Received: March 7, 2012; Accepted: March 15, 2012; Published: April 20, 2012
Copyright: © 2012 Schmidt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant 0315668A from the Federal Ministry of Education and Research of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Vitamin D deficiency has become a widespread public health problem . Humans normally get vitamin D from sunlight exposure, from their diets or dietary supplements. Seasonal variations of ultraviolet (UV)-B light exposure, increasing indoor activities, and the frequent use of sunscreens are reasons for the low synthesis of cutaneous vitamin D. These people strongly depend on dietary sources of vitamin D. Recent data, however, revealed that the prevalence of inadequate vitamin D intake is very high in large parts of Europe .
The classical role of calcitriol (1,25(OH)2D3), the bioactive form of vitamin D3, is to maintain calcium homeostasis and to promote bone mineralisation . However, a growing body of evidence suggests that vitamin D could also modify the risk for cardiovascular diseases. Several longitudinal observational cohort analyses found low plasma concentrations of 25(OH)D associated with an increased risk for incident of cardiovascular diseases – and observational studies found reduced cardiovascular mortality in patients with chronic kidney disease that received calcitriol , . Since atherosclerotic degeneration of blood vessels is often the basic underlying pathology of cardiovascular outcomes, the question arises whether vitamin D would have any causal role in pathological vascular changes. Compared to the huge number of association studies, there have been only few studies on the mechanistic effects of vitamin D deficiency on the vascular wall. Recent data from vitamin D receptor knockout (VDR−/−) mice, an animal model that emulates vitamin D deficiency , revealed a far greater number of fibrotic lesions in the hearts of these mice compared to those of the wild-type mice . However, aortic valves and blood vessels of VDR−/− mice had not been investigated in this study. In a mouse model of chronic kidney disease, activators of vitamin D receptor such as calcitriol and paricalcitrol were effective in protection against aortic calcification in dosages that normalize secondary hyperparathyoidism, whilst higher dosages stimulated aortic calcification . In 2010, Takeda et al. demonstrated that orally administered calcitriol reduced atherosclerotic lesion formation in ApoE null mice . To our knowledge, the physiological impact of a lack of vitamin D, and particularly a lack of its native form, as reflected by the 25-hydroxy-vitamin D (25OHD) on vascular composition and atherosclerotic plaque development remains largely unexplored.
The aim of the present work was to investigate aortic valve and vessel composition in response to VDR deficiency by use of a VDR−/− mouse model. Since, we were able to show, for the first time, that VDR−/− mice compared to wild-type mice showed detectable numbers of calcified spots in their aortic valves, accompanied by an up-regulation of osteogenic key factors, we wanted to examine whether the observable changes in calcification are also seen in animals fed a low vitamin D diet. Therefore a second experiment was conducted with LDL receptor knockout (LDLR−/−) mice that were investigated for aortic vessel composition and protein expression in response to a low vitamin D diet and diets that contain recommended or high amounts of vitamin D.
Impact of VDR deficiency on body weight and blood vessel composition.
At the end of the feeding period the VDR−/− mice weighed less than the WT mice (VDR−/−: 22.9±3.3 g, WTRD: 26.1±1.5 g, WTND: 25.2±1.5 g; P<0.05). Analysis of aortic root cross-sections revealed no detectable atherosclerotic lesions in any of the mice. During preparation and dissection of the blood vessels we noticed that aortas of VDR−/− mice had been more fragile than those of the WT mice. Von Kossa staining revealed that calcification areas of aortic valves of VDR−/− mice were 4.7 times greater than those of the WTRD mice, and 2.6 times greater than those of the WTND mice (P<0.001; Figure 1). No significant differences in calcification areas were observed between the two groups of WT mice. Figure 1C demonstrate that VDR−/− mice had a markedly higher number of calcified spots within the aortic cross section than WT mice. The increased number of calcified spots was comprised by a higher number of small (<10 µm2), medium (10–100 µm2) and large (>100 µm2) spots, respectively, compared to WT mice. The total number of calcified spots and the number of small, medium and large-sized spots were comparable between the two WT groups.
Panel A shows representative von Kossa stained aortic root sections of VDR−/− mice fed a rescue diet, WT mice fed a rescue diet (WTRD) and WT mice fed a normal calcium/phosphorus diet (WTND) for 8 weeks (×10). The bottom panel shows a magnification of the inserts in the top panel. Panel B shows the relative calcification area of the aortic sections and panel C the number of small-, medium- and large-sized calcified areas within an aortic cross-section. Data are means ± SD of 6–9 mice per group. a,b Bars with different superscript letters differ, P<0.015.
Impact of VDR deficiency on osteoblast differentiation factors in aortic roots.
To gain insight into the mechanisms underlying the effect of VDR deficiency on vascular calcification, aortic valve sections were immunohistochemically characterised for osteoblast differentiation factors. As shown in Figure 2, VDR−/− mice had 3 to 6 times higher protein levels of Bmp2 (P<0.001), Msx2 (P<0.001), and Runx2 (P<0.001) than WT mice. No differences in Bmp2, Msx2, and Runx2 were observed between WTRD and WTND mice, respectively (Figure 2).
Panel A shows representative aortic root sections immunohistochemically stained for Bmp2, Msx2 and Runx2 from VDR−/− mice fed a rescue diet, WT mice fed a rescue diet (WTRD) and WT mice fed a normal calcium/phosphorus diet (WTND) for 8 weeks (×10). Panel B shows the percentage of stained areas relative to the total cross-section. Data are means ± SD of 6–9 mice per group. a,b Bars with different superscript letters differ, P<0.015.
Plasma concentration of calcium was lower in the VDR−/− mice than in the WT mice (VDR−/−: 1.77±0.24 mmol/L, WTRD: 2.28±0.04 mmol/L, WTND: 2.30±0.07 mmol/L; P<0.001). Circulating concentration of total phosphorus (organic and inorganic) in the VDR−/− group was higher than in the WT group fed the normal calcium diet (VDR−/−: 6.37±0.25 mmol/L, WTRD: 6.12±0.44 mmol/L, WTND: 5.62±0.67 mmol/L; P<0.05). However, plasma concentrations of inorganic phosphate were not different between the three groups of mice (VDR−/−: 1.69±0.26 mmol/L, WTRD: 1.63±0.32 mmol/L, WTND: 1.69±0.19 mmol/L).
Impact of vitamin D deficiency on body weight, plasma lipids and vitamin D status of the LDLR−/− mice.
The body weights of LDLR−/− mice that were fed diets with low, recommended or high levels of vitamin D3 for 16 weeks did not differ (Table 1). The plasma concentrations of triglycerides and cholesterol were also not different between the three groups of mice (Table 1). As expected, the vitamin D status of mice, determined as plasma concentrations of 25(OH)D3, 24,25(OH)2D3, and 1,25(OH)2D3 was strongly influenced by the vitamin D3 concentrations in the diets (Figure 3; P<0.001). Mice fed the low vitamin D diet had the lowest plasma concentrations of 25(OH)D3 and 24,25(OH)2D3, followed by mice that received recommended amounts of vitamin D; the highest plasma levels were observed in the high vitamin D group. Mice fed the diets with low and high concentrations of vitamin D had suppressed levels of circulating 1,25(OH)2D3 compared to mice fed a diet that contained recommended amounts of vitamin D (Figure 3, P<0.05). To gain information about the intracellular genomic effects of vitamin D in response to the vitamin D diet, the aortic mRNA abundancy of calbindin D9 k as a classical target gene of the bioactive vitamin D was measured. The relative mRNA concentration of calbindin D9 k in the aorta increased with increasing dietary intake of vitamin D (Figure 3, P<0.05). The differences in the vitamin D status, however, were not accompanied by any differences in the concentrations of calcium, total or inorganic phosphate in plasma and femur (Table 2).
Plasma concentrations of 25(OH)D3, 24,25(OH)2D3, 1,25(OH)2D3, and relative mRNA abundancy of aortic calbindin D9 k of LDLR−/− mice fed a Western diet with low (50 IU/kg), recommended (1,000 IU/kg), or high (10,000 IU/kg) levels of vitamin D3 for 16 weeks. Data are means ± SD of 4 probes per group (pools of 3 samples) for analysis of 1,25(OH)2D3 and 12 mice per group for all other analyses. a,b,c Bars with different superscript letters differ, P<0.05.
Impact of a low vitamin D diet on composition of aortic roots of the LDLR−/− mice.
Data revealed that mice of all groups developed severe atherosclerosis. Thirty-five to 38% of the aortic root section areas comprised of plaque lesions (Table 3). The level of vitamin D in the diet had no influence on the atherosclerotic plaque sizes (Table 3). However, aortic sections showed more calcified lesions in mice fed the low vitamin D diet than in mice fed recommended or high amounts of vitamin D (+58%, +120%, respectively, Figure 4; P<0.001). Mice treated with the high vitamin D diet tended to have less aortic calcification areas (−28%) than mice fed recommended amounts (P<0.10). Figure 4C demonstrate that LDLR−/− mice that were fed the low vitamin D diet had a markedly higher number of calcified spots within the aortic cross section than LDLR−/− fed diets with recommended and high amounts of vitamin D. The increased number of calcified spots was mainly due to a higher number of small (<10 µm2) and medium (10–100 µm2) spots but not due to a higher number of large (>100 µm2) spots. Mean plaque levels of collagen, lipids, macrophages and smooth muscle cells were not different between the three groups of LDLR−/− mice (Table 3).
Panel A shows representative von Kossa stained aortic sections from LDLR−/− mice kept for 16 weeks on a Western diet with either low (50 IU/kg), recommended (1,000 IU/kg) or high (10,000 IU/kg) vitamin D3 levels (×10). The bottom panel shows a magnification of the inserts in the top panel. Panel B shows the relative calcification area of the aortic sections and panel C the number of small-, medium- and large-sized calcified areas within an aortic cross-section. Data are means ± SD of 12 mice per group. a,b Bars with different superscript letters differ, P<0.015.
Impact of vitamin D deficiency on osteoblast differentiation factors in aortic roots of the LDLR−/− mice.
Since aortic calcification in the VDR−/− mice was associated with the up-regulation of osteogenic key factors, we analysed these factors in the LDLR−/− mouse model, too. Aortic Bmp2, Msx2 and Runx2 were higher in the low vitamin D group than in the groups fed recommended or high levels of vitamin D (P<0.01; Figure 5). Figure 5 shows further no differences of Msx2 and Runx2 between mice fed recommended and high levels of vitamin D, but mice fed the high vitamin D diet had lower Bmp2 levels than mice fed the recommended amounts (P<0.001).
Panel A shows representative aortic cross sections immunohistochemically stained for Bmp2, Msx2 and Runx2 from LDLR−/− mice kept for 16 weeks on a Western diet with either low (50 IU/kg), recommended (1,000 IU/kg) or high (10,000 IU/kg) vitamin D3 levels (×10). Panel B shows the percentage of stained areas relative to the total cross-section. Data are means ± SD of 12 mice per group. a,b,c Bars with different superscript letters differ, P<0.015.
Several studies found strong associations between hypovitaminosis D and cardiovascular diseases –. In the mouse experiments reported here, VDR knockout and diet-induced reduction of vitamin D status resulted in enhanced aortic valve and vascular calcification. Thus, the observed association of low serum 25(OH)D and high vascular calcifications in humans  appears to be causally linked. The results obtained from the VDR−/− mouse study further revealed that calcification seems to be independent from other vascular processes because aortic valves of VDR−/− mice became significantly calcified despite any identifiable atherosclerotic plaques. Vascular calcification is being associated with reduced arterial elastance, and compromised structural integrity , . We assume that the observed vascular instability during preparation and dissection of aortas from VDR−/− mice was, at least in part, caused by the presence of more calcified deposits at the level of aortic root compared to the WT mice. Not all vascular calcification occurs in the presence of atherosclerosis. Data from our VDR−/− mouse study show that vascular mineralization was not simply the consequence of accelerated atherosclerosis because calcification occurred in vessel walls that were free of any atherosclerotic plaques. However, when considering the number of calcified spots of defined sizes within the cross sections, data clearly show that VDR−/− had not only a higher number of small-sized spots, but also a higher number of medium- and large-sized spots compared to WT mice. Similar findings were observed in the LDLR−/− mouse study, in which mice fed the low vitamin D diet had a higher number of small- and medium-sized calcified spots than mice fed recommended and high amounts of vitamin D. However, the number of large-sized spots was very low in all groups of these mice.
Analyses of human populations at high and moderate risk for coronary heart disease showed that circulating plasma concentrations of calcitriol were inversely correlated with the extent of vascular calcification in both groups . Results from the LDLR−/− mouse study revealed that mice fed the high vitamin D diet had less vascular calcification than mice fed the low vitamin D diet although plasma levels of 1,25(OH)2D3 were not different between these two groups. It is well-known that a high intake of vitamin D might lead to a reduction of plasma calcitriol levels via down-regulation of renal CYP27B1, an enzyme that converts 25(OH)D to 1,25(OH)2D . We therefore assume that the described negative correlation between vascular calcification and plasma calcitriol only applies in cases of low plasma levels of calcitriol caused by chronic kidney diseases, low cutaneous vitamin D synthesis or low intake of dietary vitamin D but not in cases of reduced calcitriol levels induced by high vitamin D intake. Thus, intake of high doses of native vitamin D may differ in its effects on cardiovascular calcification when compared with high-doses of active vitamin D, i.e. calcitriol, since the levels of 1,25(OH)2D are not the same in these two states. Although the circulating concentrations of 25(OH)D, and 24,25(OH)2D and the vascular mRNA concentration of calbindin D9 k reflect quite well the vitamin D status, levels beyond those obtained with recommended amount of dietary vitamin D were not associated with a further reduction of vascular calcification. Thus, the biphasic dose-response curve of vitamin D on vascular calcification may not necessarily be applicable to native dietary vitamin D.
Arterial calcification is a common feature of atherosclerosis ,  and is supposed to contribute to an increased risk of vascular dissection during angioplasty , myocardial infarction  and mortality in patients with advanced atherosclerosis . Vascular calcification is a complex process that involves numerous regulating factors and seems to share many similarities to skeletal mineralization and osteogenesis  because vascular smooth muscle cells and osteoblasts derive from the same mesenchymal precursor cell. Morphogenetic proteins Runx2, Msx2 and Bmp2 are involved in the transformation of vascular smooth muscle cells into osteoblast-like cells –. Results from our experiments indicate that the increased calcification of VDR−/− mice and LDLR−/− mice that received the low vitamin D diet was driven by these morphogenic proteins, because aortic Runx2, Msx2, and Bmp2 were up-regulated in these animals. Bmp2 has been identified as a crucial mediator of calcification because it up-regulates Msx2 and Runx2 which are key regulators of osteoblastic differentiation . Runx2 expression in vascular smooth muscle cells has been considered identified as an early marker of osteoblastic differentiation, the initial step in vascular calcification . Several factors that contribute to vascular calcification induce Runx2 expression, including increased inorganic phosphate concentration , . The classical function of active vitamin D is to maintain the homeostasis of calcium and phosphorus and to keep their concentrations in the plasma constant. The findings that the circulating plasma concentration of inorganic phosphate did not differ between the VDR−/− and WT mice, as well as among the LDLR−/− mice reveal that calcium and inorganic phosphate are not the crucial factors that determine vascular calcification in the vitamin D deficiency state.
In conclusion, our findings show that VDR deficiency and diets low in vitamin D promote aortic valve and aortic vessel calcification in the VDR−/− and LDLR−/− mouse models. The vascular calcification was associated with an up-regulation of osteoblast transcription factors which could have triggered the differentiation of vascular cells into osteoblast-like cells. We assume that an optimization of circulating 25(OH)D levels therefore could contribute to prevent vascular and aortic valve calcification and in consequence cardiovascular outcomes associated with those calcification processes.
Materials and Methods
Mice and Diets
All animal experiments described were carried out in accordance with established guidelines for the care and handling of laboratory animals and were approved by the council of Saxony-Anhalt (Permit number: 42502-5-34 MLU). Two studies were conducted. Animals were housed in cages on a 12-h-light/-dark cycle and consumed food and water ad libitum. Body weights and food intake were recorded weekly.
In the first experiment, male 5-weeks-old VDR−/− mice (B6.129S4-VdrtmlMbd/J; Jackson Laboratory, Bar Harbor, Maine, USA) and corresponding WT mice (C57BL/6J; Charles River Laboratories, Sulzfeld, Germany) were fed a semi-synthetic Western diet (20% sucrose, 20% coconut oil, 0.15% cholesterol) for 8 weeks. The VDR−/− group (n = 6) was maintained on a high-calcium (2%), high-phosphorus (1.25%) rescue diet to prevent hypocalcaemia secondary to VDR deficiency. One group of WT mice (WTRD, n = 8) received the same rescue diet as the VDR−/− group. The other group of WT mice (WTND, n = 8) received a normal calcium/normal phosphorus diet (0.3% calcium, 0.156% phosphorus) according to the recommendations of the National Research Council (NRC)  Each group received 20% lactose with their diet to improve intestinal calcium uptake.
In the second experiment, a total of thirty-six 4-weeks-old male LDLR−/− mice (B6.129S7-Ldlrtm1Her/J; Jackson Laboratory) were assigned to three groups of 12 mice each and were fed a semi-synthetic Western diet (20% sucrose, 21% lard, 0.15% cholesterol) containing either 50 (low), 1,000 (recommended ), or 10,000 (high) IU vitamin D3/kg diet for 16 weeks. The other vitamins and minerals were supplemented according to recommendations of the NRC .
Mice were deprived of food overnight prior to killing under light anesthesia with diethyl ether. Blood was collected into EDTA tubes. Plasma was separated by centrifugation at 1500×g for 20 min and stored at −20°C until further analysis. Aortic roots were harvested of all mice for histochemical and immunohistochemical analysis. From LDLR−/− mice, femur was excised for calcium and phosphorus analysis. All tissue samples were immediately snap-frozen in liquid N2 and stored at −80°C.
Analysis of Plasma 25(OH)D3, 24,25(OH)2D3 and 1,25(OH)2D3
Analysis of 25(OH)D3 and 24,25(OH)2D3 was done by a modified HPLC-MS/MS method  using an API 2000 (ABSCIEX, Darmstadt, Germany) in ESI mode coupled to an 1100 HPLC and Hypersil ODS column (100×2.1 mm2, 5 µm, Agilent Technologies, Waldbronn, Germany). Sample preparation was modified by mixing 50 µL of plasma and 50 µL of internal standard (25 µg/L 25(OH)D3-d6, Chemaphor Inc., Ottawa, Canada) in acetonitrile, followed by extraction with 400 µL n-hexane. After evaporation, 50 µL of 4-phenyl-1,2,4-triazoline-3,5-dione (0.15 g/L) in acetonitrile were added and incubated overnight. The samples were then mixed with 20 µL of ethanol, incubated for 30 min and dried under vacuum afterwards. The residues were dissolved in 40 µL of the mobile phase. Multilevel Serum Calibrator Set (Chromsystems, Munich, Germany) and horse serum spiked with 24,25(OH)2D3 (Enzo Life Sciences, Lörrach, Germany) were used for calibration. Plasma concentration of 1,25(OH)2D3 was determined by use of a commercial enzyme immunoassay (IDS, Boldon, UK).
Analysis of Calcium and Phosphorus in Plasma and Femur
The concentration of calcium and total phosphorus (organic and inorganic) in plasma and femur was measured by inductively coupled plasma optical emission spectrometry (ICP-OES, Varian 715-ES ICP Optical Emission Spectrometer, Agilent Technologies, Santa Clara, California, USA; ICP Expert II Varian 715-ES Instrument Software, Version 1.1.3) using argon as carrier gas. Prior to analysis of calcium and phosphorus at selected wavelengths, femurs were ashed in a muffle furnace at 550°C and dissolved in HCl and HNO3 according to the official VDLUFA method . After evaporation, the minerals were resolved in distilled water, filtered and injected in the ICP-OES system. The plasma concentration of inorganic phosphate was measured spectrophotometrically according to the manufacturers' protocol (Fluitest PHOS; Biocon Diagnostik, Vöhl/Marienhagen, Germany).
Analysis of Triglycerides and Cholesterol in Plasma
Concentrations of triglycerides and cholesterol in plasma were examined using enzymatic reagent kits (DiaSys Diagnostic Systems, Holzheim, Germany, no. 1.1300 99 90 314 and 1.5760 99 90 314).
Preparation and Morphometric Analysis of Aortic Roots
For preparation of the aortic root sections, the vasculature was perfused with 0.9% NaCl, and the ventricular edge and approximately 1 mm of the aortic root were immediately dissected under a stereomicroscope and cryo-mounted in mounting medium (tissue freezing medium®, Jung; Leica Instruments, Nussloch, Germany). To quantify atherosclerosis at the aortic root, serial 7 µm thick slices (CM 1850 UV microtome, Jung; Leica) were collected, beginning at the aortic valve area. Four sections each were stained with haematoxylin-eosin (sections from 0 to 28 µm), Mallory-Cason's trichrome for collagen structures (sections from 112 to 140 µm), von Kossa for vascular calcification (sections from 154 to 182 µm) and Oil red O for vascular lipids (sections from 196 to 224 µm). Histomorphological characterization and computerized morphometric quantification (Axiovert 200 microscope; AxioCamMRc; Axiovision Rel. 4.8.2 software (all Carl Zeiss, Jena, Germany)) of the atherosclerotic lesions were performed. The cross-sectional surface area of the total vessel, the atherosclerotic lesion area as well as the calcification area, the collagen area and the lipid area were assessed to characterize atherosclerosis development in the aortic root.
Immunohistochemical Analysis of Aortic Roots
For immunohistochemistry aortic root sections were immediately fixed in acetone at −20°C for 10 min, and endogenous peroxidase was blocked with 0.3% H2O2 in methanol. Following a washing step, the sections were incubated each with 5% blocking serum in PBS at room temperature for 20 min. Sections were incubated with primary antibodies against CD68 (AbD Serotec, Oxford, UK; sections from 28 to 56 µm), SMC α-actin (Sigma-Aldrich, Taufkirchen, Germany; sections from 56 to 84 µm), Bmp2 (abcam, Cambridge, UK; sections from 84 to 112 µm), Runx2 (antibodies-online.de, Atlanta, USA; sections from 140 to 154 µm ) and Msx2 (Sigma-Aldrich; sections from 182 to 196 µm) over night at 4°C, followed by incubation with horseradish peroxidase-labeled secondary antibodies (goat anti-rat IgG (AbDSerotec, Oxford, UK) and rabbit anti-mouse IgG (Dako, Hamburg, Germany) at room temperature for 30 min. The immunocomplex was visualized using diaminobenzidine chromogen (Dako). Sections were counterstained with Harris haematoxylin solution. Stained slices were evaluated for the presence and intensity of positive reaction using Axiovision Rel. 4.8.2 software.
RNA Isolation and real time RT-PCR
For the determination of aortic calbindin D9 k mRNA expression level, total RNA was isolated from the aortic arch using TrizolTM reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's protocol. RNA concentration and purity were estimated from the optical density at 260 and 280 nm, respectively. Total RNA (1.2 µg) was subjected to first-strand cDNA synthesis at 42°C for 60 min using M-MuLV RT (MBI Fermentas, St. Leon-Rot, Germany) and oligo dT18-primer (Operon Biotechnologies, Cologne, Germany). PCR was performed with the Rotor Gene 2000 system (Corbett Research, Mortlake, Australien). Real-time detection was carried out by using SYBR® Green I (Sigma), 1.25 U Taq DNA polymerase (Promega, Mannheim, Germany), 500 µM dNTP and 26.7 pmol of specific primers for calbindin D9 k (NM_009789.2; forward 5′TCA CCT GCT GTT CCT GTC TG 3′; reverse 5′ TCG CCA TTC TTA TCC AGC TC 3′, Operon Biotechnologies). Each PCR cycle compromised denaturation for 20 s at 95°C, annealing for 30 s at 60°C and elongation at 72°C for 55 s. At the end of the elongation step, the intensity of fluorescence in all probes was measured. The threshold cycle (Ct) and the amplification efficiency were obtained from each amplification curve using the software RotorGene 4.6 (Corbett Research). For identification of the PCR products, melting-curve analysis and agarose (1.5%) gel electrophoresis were performed. The housekeeping gene β-actin (NM_007393.2; forward 5′ACG GCC AGG TCA TCA CTA TTG 3′; reverse 5′ CAC AGG ATT CCA TAC CCA AGA AG 3′, Operon Biotechnologies) was used for normalization.
Values presented in the text are means and standard deviations. Treatment effects were analyzed by one-way ANOVA using MINITAB software (Minitab, State College, PA, USA). For statistically significant F values, means were compared by Fisher's multiple-comparison test. Means were considered to be significantly different at P<0.05.
Conceived and designed the experiments: GIS. Performed the experiments: NS CB HK. Analyzed the data: NS CB HK AT FH. Wrote the paper: NS GIS.
- 1. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, et al. (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260: 245–254.P. LipsD. HoskingK. LippunerJM NorquistL. Wehren2006The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation.J Intern Med260245254
- 2. Viñas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, et al. (2011) Projected prevalence of inadequate nutrient intakes in Europe. Ann Nutr Metab 59: 84–95.BR ViñasLR BarbaJ. NgoM. GurinovicR. Novakovic2011Projected prevalence of inadequate nutrient intakes in Europe.Ann Nutr Metab598495
- 3. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr, et al. (1980) Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210: 203–205.MF HolickJA MacLaughlinMB ClarkSA HolickJT Potts Jr1980Photosynthesis of previtamin D3 in human skin and the physiologic consequences.Science210203205
- 4. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340–1349.H. DobnigS. PilzH. ScharnaglW. RennerU. Seelhorst2008Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.Arch Intern Med16813401349
- 5. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174–1180.E. GiovannucciY. LiuBW HollisEB Rimm200825-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.Arch Intern Med16811741180
- 6. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511.TJ WangMJ PencinaSL BoothPF JacquesE. Ingelsson2008Vitamin D deficiency and risk of cardiovascular disease.Circulation117503511
- 7. Artaza JN, Mehrotra R, Norris KC (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4: 1515–1522.JN ArtazaR. MehrotraKC Norris2009Vitamin D and the cardiovascular system.Clin J Am Soc Nephrol415151522
- 8. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, et al. (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170: 1032–1039.A. KilkkinenP. KnektA. AroH. RissanenJ. Marniemi2009Vitamin D status and the risk of cardiovascular disease death.Am J Epidemiol17010321039
- 9. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B (2008) Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19: 1613–1619.AB ShobenKD RudserIH de BoerB. YoungB. Kestenbaum2008Association of oral calcitriol with improved survival in nondialyzed CKD.J Am Soc Nephrol1916131619
- 10. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19: 1379–1388.M. WolfJ. BetancourtY. ChangA. ShahM. Teng2008Impact of activated vitamin D and race on survival among hemodialysis patients.J Am Soc Nephrol1913791388
- 11. Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662–687.S. NagpalS. NaR. Rathnachalam2005Noncalcemic actions of vitamin D receptor ligands.Endocr Rev26662687
- 12. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103: 416–419.A. RahmanS. HersheyS. AhmedK. NibbelinkRU Simpson2007Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice.J Steroid Biochem Mol Biol103416419
- 13. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19: 1509–1519.S. MathewRJ LundLR ChaudharyT. GeursKA Hruska2008Vitamin D receptor activators can protect against vascular calcification.J Am Soc Nephrol1915091519
- 14. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, et al. (2010) Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30: 2495–2503.M. TakedaT. YamashitaN. SasakiK. NakajimaT. Kita2010Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions.Arterioscler Thromb Vasc Biol3024952503
- 15. Cannata-Andia JB, Rodrigues-Garcia M, Carrillo-Lopez N, Diaz-Naves , Diaz-Lopez B (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17: S267–S273.JB Cannata-AndiaM. Rodrigues-GarciaN. Carrillo-LopezDiaz-NavesB. Diaz-Lopez2006Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.J Am Soc Nephrol17S267S273
- 16. Kelly RP, Tunin R, Kass DA (1992) Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res 71: 490–502.RP KellyR. TuninDA Kass1992Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle.Circ Res71490502
- 17. Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24: 331–336.MA AllisonMH CriquiCM Wright2004Patterns and risk factors for systemic calcified atherosclerosis.Arterioscler Thromb Vasc Biol24331336
- 18. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755–1760.KE WatsonML AbrolatLL MaloneJM HoegT. Doherty1997Active serum vitamin D levels are inversely correlated with coronary calcification.Circulation9617551760
- 19. Fleet JC, Gliniak C, Zhang Z, Xue Y, Smith KB, et al. (2008) Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J Nutr 138: 1114–1120.JC FleetC. GliniakZ. ZhangY. XueKB Smith2008Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice.J Nutr13811141120
- 20. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827–832.AS AgatstonWR JanowitzFJ HildnerNR ZusmerM. Viamonte Jr1990Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol15827832
- 21. Breslow JL (1997) Cardiovascular disease burden increases, NIH funding decreases. Nat Med 3: 600–601.JL Breslow1997Cardiovascular disease burden increases, NIH funding decreases.Nat Med3600601
- 22. Braunwald E (1997) Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337: 1360–1369.E. Braunwald1997Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.N Engl J Med33713601369
- 23. Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180: 1332–1339.R. RossJA Glomset1973Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.Science18013321339
- 24. Abedin M, Tintut Y, Demer LL (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161–1170.M. AbedinY. TintutLL Demer2004Vascular calcification: mechanisms and clinical ramifications.Arterioscler Thromb Vasc Biol2411611170
- 25. Mizobuchi M, Towler D, Slatopolsky E (2009) Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20: 1453–1464.M. MizobuchiD. TowlerE. Slatopolsky2009Vascular calcification: the killer of patients with chronic kidney disease.J Am Soc Nephrol2014531464
- 26. Zebboudi AF, Shin V, Bostrom K (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90: 756–765.AF ZebboudiV. ShinK. Bostrom2003Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells.J Cell Biochem90756765
- 27. Towler DA, Shao JS, Cheng SL, Pingsterhaus JM, Loewy AP (2006) Osteogenic regulation of vascular calcification. Ann N Y Acad Sci 1068: 327–333.DA TowlerJS ShaoSL ChengJM PingsterhausAP Loewy2006Osteogenic regulation of vascular calcification.Ann N Y Acad Sci1068327333
- 28. Speer MY, Li X, Hiremath PG, Giacelli CM (2010) Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem 110: 935–947.MY SpeerX. LiPG HiremathCM Giacelli2010Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.J Cell Biochem110935947
- 29. Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99: 1044–1059.RC JohnsonJA LeopoldJ. Loscalzo2006Vascular calcification: pathobiological mechanisms and clinical implications.Circ Res9910441059
- 30. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H (1999) Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2112–2118.K. MoriA. ShioiS. JonoY. NishizawaH. Morii1999Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells.Arterioscler Thromb Vasc Biol1921122118
- 31. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, et al. (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147–1154.SA SteitzMY SpeerG. CuringaHY YangP. Haynes2001Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.Circ Res8911471154
- 32. National Research Council (NRC), Committee on Animal Nutrition (1995) Nutrient Requirements of Laboratory Animals. Washington, D.C.: National Academy Press. pp. 80–102.National Research Council (NRC), Committee on Animal Nutrition1995Nutrient Requirements of Laboratory AnimalsWashington, D.C.National Academy Press80102
- 33. Higashi T, Shibayama Y, Fuji M, Shimada K (2008) Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal Bioanal Chem 391: 229–238.T. HigashiY. ShibayamaM. FujiK. Shimada2008Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status.Anal Bioanal Chem391229238
- 34. Bassler R, Buchholz H (1993) Die chemische Untersuchung von Futtermitteln. Band II. Darmstadt: VDLUFA Verlag. R. BasslerH. Buchholz1993Die chemische Untersuchung von Futtermitteln. Band IIDarmstadtVDLUFA Verlag